M9S-13465-54487
4 vaccinations
1 coded response
15 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 322 / FL
- Registered
- 2022-11-05
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Registered dependents
2C2-40288-03853
Child or adolescent in my care · Male · 2022-11-05
NS3-89291-07554
Child or adolescent in my care · Female · 2022-11-05
Timeline
-
2021-03-28
Dose 1 — Pfizer-BioNTech
-
2021-04-18
Dose 2 — Pfizer-BioNTech
-
2021-11-24
Dose 3 — Pfizer-BioNTech
-
2022-11-05
Registered in v-safe
-
2022-11-05
Dose 4 — Pfizer-BioNTech
- 2022-11-05
- 2022-11-06
- 2022-11-07
- 2022-11-08
- 2022-11-09
- 2022-11-10
- 2022-11-11
- 2022-11-12
- 2022-11-19
- 2022-11-26
- 2022-12-03
- 2022-12-10
- 2022-12-17
- 2023-02-04
-
2023-05-08
Survey response — 6 months, dose 4MedDRA: Headache, Nasal congestion — Feeling: FairMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-28 | Pfizer-BioNTech | No |
| 2 | 2021-04-18 | Pfizer-BioNTech | No |
| 3 | 2021-11-24 | Pfizer-BioNTech | No |
| 4 | 2022-11-05 | Pfizer-BioNTech | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release